Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists
Med Page Today
APRIL 10, 2024
(MedPage Today) -- A Scandinavian cohort study suggested a popular class of diabetes drug did not put patients at an elevated risk for thyroid cancer, a longtime lingering concern with this drug class. Compared with DPP-4 inhibitors, patients.
Let's personalize your content